Lasa Supergenerics balance sheet

As of Mar 2026

Total assets: ₹66.3cr−34.7% on Mar 2025
Shareholders' equity: ₹49.6cr−40.7% on Mar 2025
Total debt: ₹9.7cr+279.3% on Mar 2025
Cash and investments: ₹0.3cr+4.5% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	38.4	48.1	83.8	88.1
	0.0	0.2	2.5	4.6
	0.0	0.0	11.7	0.0
	0.0	19.9	14.3	30.8
	16.7	0.0	—	0.0
	0.0	0.0	0.0	0.4
	0.8	0.8	0.7	0.6
	0.8	0.8	0.7	1.0
	55.8	69.0	113	125
	1.8	24.5	19.0	13.9
	0.0	1.5	3.6	2.5
	0.3	0.3	0.6	0.8
	0.4	0.5	0.9	1.6
	0.1	0.1	0.1	0.1
	—	0.0	13.7	20.4
	0.8	2.3	18.8	25.3
	7.8	5.7	—	0.0
	10.4	32.5	37.9	39.2
	66.3	102	151	164
Equity
	50.1	50.1	50.1	50.1
	−0.5	33.6	46.6	68.2
	49.6	83.7	96.7	118
	49.6	83.7	96.7	118
Liabilities
	0.0	0.4	0.0	0.0
	0.0	0.4	0.0	0.0
	0.2	0.0	0.5	0.6
	−0.3	0.2	4.8	2.2
	−0.1	0.7	5.3	2.8
	9.7	2.1	22.1	0.0
	2.1	10.2	14.1	9.4
	—	0.0	0.0	21.8
	11.9	12.3	36.1	31.2
	2.3	0.0	11.3	10.1
	0.0	1.5	—	0.0
	2.6	3.3	1.5	1.4
	16.8	17.2	48.9	42.7
	16.6	17.8	54.2	45.6
	66.3	102	151	164
Trade payables — MSME split
	0.2	4.4	—	—
	1.9	5.9	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), standalone. For information only, not investment advice.

alphave

LASA₹4.67

Lasa Supergenerics Limited

· Pharma & Health

₹ CrorePeersMANGALAM BIOFILCHEM ORTINGLOBE VINEETLAB KREBSBIO ALPA BALPHARMA NATCAPSUQMcap ₹23.4 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	88.1	83.8	48.1	38.4	38.4
+ Capital Work-in-Progress	4.6	2.5	0.2	0.0	0.0
+ Goodwill	0.0	11.7	0.0	0.0	0.0
+ Other Intangibles	30.8	14.3	19.9	0.0	0.0
+ Intangibles under Development	0.0	—	0.0	16.7	16.7
+ Non-current Investments	0.4	0.0	0.0	0.0	0.0
+ Other Non-current Financial Assets	0.6	0.7	0.8	0.8	0.8
Non-current Financial Assets	1.0	0.7	0.8	0.8	0.8
Total Non-current Assets	124.6	113.0	69.0	55.8	55.8
Current Assets
+ Inventories	13.9	19.0	24.5	1.8	1.8
+ Trade Receivables	2.5	3.6	1.5	0.0	0.0
+ Cash & Cash Equivalents	0.8	0.6	0.3	0.3	0.3
+ Other Bank Balances	1.6	0.9	0.5	0.4	0.4
+ Short-term Loans	0.1	0.1	0.1	0.1	0.1
+ Other Current Financial Assets	20.4	13.7	0.0	—	—
Current Financial Assets	25.3	18.8	2.3	0.8	0.8
+ Other Current Assets	0.0	—	5.7	7.8	7.8
Total Current Assets	39.2	37.9	32.5	10.4	10.4
Total Assets	163.9	150.9	101.5	66.3	66.3
Equity
+ Equity Share Capital	50.1	50.1	50.1	50.1	50.1
+ Other Equity / Reserves	68.2	46.6	33.6	-0.5	-0.5
Equity — Owners of Parent	118.3	96.7	83.7	49.6	49.6
Total Equity	118.3	96.7	83.7	49.6	49.6
Liabilities
+ Borrowings — Non-current	0.0	0.0	0.4	0.0	0.0
Non-current Financial Liabilities	0.0	0.0	0.4	0.0	0.0
+ Provisions — Non-current	0.6	0.5	0.0	0.2	0.2
+ Deferred Tax Liabilities	2.2	4.8	0.2	-0.3	-0.3
Non-current Liabilities	2.8	5.3	0.7	-0.1	-0.1
+ Borrowings — Current	0.0	22.1	2.1	9.7	9.7
+ Trade Payables	9.4	14.1	10.2	2.1	2.1
+ Other Current Financial Liab	21.8	0.0	0.0	—	—
Current Financial Liabilities	31.2	36.1	12.3	11.9	11.9
+ Provisions — Current	10.1	11.3	0.0	2.3	2.3
+ Current Tax Liabilities	0.0	—	1.5	0.0	0.0
+ Other Current Liabilities	1.4	1.5	3.3	2.6	2.6
Current Liabilities	42.7	48.9	17.2	16.8	16.8
Total Liabilities	45.6	54.2	17.8	16.6	16.6
Total Equity & Liabilities	163.9	150.9	101.5	66.3	66.3
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	4.4	0.2	0.2
+ Dues to Other Creditors — Current	—	—	5.9	1.9	1.9

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · StandaloneFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.